MyAverix Finance
F · Healthcare
CANBRIDGE PHARM.DL-00001 (MF1)
Biotechnology
CANBRIDGE PHARM.DL-00001 (MF1) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $92.61M, P/E ratio is 18.00, net margin is -217.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MF1
CANBRIDGE PHARM.DL-00001 (MF1) — FAQ
What is CANBRIDGE PHARM.DL-00001's market cap?
CANBRIDGE PHARM.DL-00001 (MF1) has a reported market cap of $92.61M (data as of 2026-03-30).
What is MF1's P/E ratio?
The price-to-earnings (P/E) ratio for CANBRIDGE PHARM.DL-00001 (MF1) is 18.00 (data as of 2026-03-30).
Does CANBRIDGE PHARM.DL-00001 pay a dividend?
Dividend yield is not available in the current snapshot for CANBRIDGE PHARM.DL-00001 (MF1). Check the MyAverix Finance app for the latest dividend data.
What sector is CANBRIDGE PHARM.DL-00001 in?
CANBRIDGE PHARM.DL-00001 (MF1) is classified in the Healthcare sector (Biotechnology industry).
What exchange is MF1 listed on?
MF1 is listed on F.
What is CANBRIDGE PHARM.DL-00001's net margin?
CANBRIDGE PHARM.DL-00001 (MF1) reports a net margin of -217.6% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.